About me
Heidi Grabenstatter, Ph.D., is the Scientific Director of the Rare Disease Cures Accelerator- Data Analytics Platform (RDCA-DAP). In this role, she leads neutral convenings of clinician experts, data scientists, industry partners, and patient advocacy leaders to identify disease-specific unmet needs and develop data-driven tools leveraging the core competencies held at Critical Path Institute (C-PATH) to improve trial design (e.g., data management and standards, biomarker development, clinical outcome measure development, model and analytics, and regulatory science), ultimately, accelerating cures for rare diseases.
